---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-063125"
form_type: "8-K"
ticker: "LRMR"
cik: "0001374690"
company_name: "Larimar Therapeutics, Inc."
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T16:53:11.267068+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Larimar posts updated corporate presentation; no material new data

## Summary
- Updated slide deck dated May 5, 2025 posted on company website.
- Presentation intended for use in meetings with investors, analysts, and other parties.
- Filing does not disclose any new financial, clinical, or operational information.

## SEC filing metadata
- accession: 0000950170-25-063125
- form_type: 8-K
- ticker: LRMR
- cik: 0001374690
- company_name: Larimar Therapeutics, Inc.
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374690/000095017025063125/0000950170-25-063125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374690/000095017025063125/lrmr-20250505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-063125
- JSON: https://secwatch.observer/filing/0000950170-25-063125.json
- Plain text: https://secwatch.observer/filing/0000950170-25-063125.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.